Motor neuron pathology in CANVAS due to RFC1 expansions.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
30 06 2022
Historique:
received: 28 07 2021
revised: 03 11 2021
accepted: 18 11 2021
pubmed: 21 12 2021
medline: 6 7 2022
entrez: 20 12 2021
Statut: ppublish

Résumé

CANVAS caused by RFC1 biallelic expansions is a major cause of inherited sensory neuronopathy. Detection of RFC1 expansion is challenging and CANVAS can be associated with atypical features. We clinically and genetically characterized 50 patients, selected based on the presence of sensory neuronopathy confirmed by EMG. We screened RFC1 expansion by PCR, repeat-primed PCR, and Southern blotting of long-range PCR products, a newly developed method. Neuropathological characterization was performed on the brain and spinal cord of one patient. Most patients (88%) carried a biallelic (AAGGG)n expansion in RFC1. In addition to the core CANVAS phenotype (sensory neuronopathy, cerebellar syndrome and vestibular impairment), we observed chronic cough (97%), oculomotor signs (85%), motor neuron involvement (55%), dysautonomia (50%), and parkinsonism (10%). Motor neuron involvement was found for 24 of 38 patients (63.1%). First motor neuron signs, such as brisk reflexes, extensor plantar responses, and/or spasticity, were present in 29% of patients, second motor neuron signs, such as fasciculations, wasting, weakness, or a neurogenic pattern on EMG in 18%, and both in 16%. Mixed motor and sensory neuronopathy was observed in 19% of patients. Among six non-RFC1 patients, one carried a heterozygous AAGGG expansion and a pathogenic variant in GRM1. Neuropathological examination of one RFC1 patient with an enriched phenotype, including parkinsonism, dysautonomia, and cognitive decline, showed posterior column and lumbar posterior root atrophy. Degeneration of the vestibulospinal and spinocerebellar tracts was mild. We observed marked astrocytic gliosis and axonal swelling of the synapse between first and second motor neurons in the anterior horn at the lumbar level. The cerebellum showed mild depletion of Purkinje cells, with empty baskets, torpedoes, and astrogliosis characterized by a disorganization of the Bergmann's radial glia. We found neuronal loss in the vagal nucleus. The pars compacta of the substantia nigra was depleted, with widespread Lewy bodies in the locus coeruleus, substantia nigra, hippocampus, entorhinal cortex, and amygdala. We propose new guidelines for the screening of RFC1 expansion, considering different expansion motifs. Here, we developed a new method to more easily detect pathogenic RFC1 expansions. We report frequent motor neuron involvement and different neuronopathy subtypes. Parkinsonism was more prevalent in this cohort than in the general population, 10% versus the expected 1% (P < 0.001). We describe, for the first time, the spinal cord pathology in CANVAS, showing the alteration of posterior columns and roots, astrocytic gliosis and axonal swelling, suggesting motor neuron synaptic dysfunction.

Identifiants

pubmed: 34927205
pii: 6470371
doi: 10.1093/brain/awab449
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2121-2132

Subventions

Organisme : Medical Research Council
ID : MR/T001712/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Vincent Huin (V)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience and Cognition, F-59000 Lille, France.

Giulia Coarelli (G)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, Genetics Department, Pitié Salpêtrière University Hospital, Sorbonne Université, Paris 75013, France.

Clément Guemy (C)

APHP, Genetics Department, Pitié Salpêtrière University Hospital, Sorbonne Université, Paris 75013, France.

Susana Boluda (S)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, Laboratoire Neuropathologie Raymond Escourolle, Pitié Salpêtrière University Hospital, Sorbonne Université, F-75013 Paris, France.

Rabab Debs (R)

APHP, Department of Neurology, Pitié Salpêtrière University Hospital, Sorbonne Université, F-75013 Paris, France.

Fanny Mochel (F)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, Genetics Department, Pitié Salpêtrière University Hospital, Sorbonne Université, Paris 75013, France.

Tanya Stojkovic (T)

Institut de Myologie, Centre de Référence de Pathologie Neuromusculaire Paris-Est, AP-HP, Pitié Salpêtrière University Hospital, Sorbonne University, Paris, France.

David Grabli (D)

APHP, Department of Neurology, Pitié Salpêtrière University Hospital, Sorbonne Université, F-75013 Paris, France.

Thierry Maisonobe (T)

Institut de Myologie, Centre de Référence de Pathologie Neuromusculaire Paris-Est, AP-HP, Pitié Salpêtrière University Hospital, Sorbonne University, Paris, France.

Bertrand Gaymard (B)

APHP, Department of Neurophysiology, Pitié Salpêtrière University Hospital, Sorbonne Université, F-75013 Paris, France.

Timothée Lenglet (T)

APHP, Department of Neurophysiology, Pitié Salpêtrière University Hospital, Sorbonne Université, F-75013 Paris, France.

Céline Tard (C)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience and Cognition, F-59000 Lille, France.
Centre de Référence des Maladies Neuromusculaires, CHU Lille, Hôpital Pierre Swynghedauw, F-59000 Lille, France.

Jean Baptiste Davion (JB)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience and Cognition, F-59000 Lille, France.
Centre de Référence des Maladies Neuromusculaires, CHU Lille, Hôpital Pierre Swynghedauw, F-59000 Lille, France.

Bernard Sablonnière (B)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience and Cognition, F-59000 Lille, France.

Marie Lorraine Monin (ML)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.

Claire Ewenczyk (C)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, Genetics Department, Pitié Salpêtrière University Hospital, Sorbonne Université, Paris 75013, France.

Karine Viala (K)

Institut de Myologie, Centre de Référence de Pathologie Neuromusculaire Paris-Est, AP-HP, Pitié Salpêtrière University Hospital, Sorbonne University, Paris, France.

Perrine Charles (P)

APHP, Genetics Department, Pitié Salpêtrière University Hospital, Sorbonne Université, Paris 75013, France.

Isabelle Le Ber (I)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, National Reference Center for "Rare and Young Dementia", IM2A, Pitié-Salpêtrière University Hospital, Sorbonne Université, F-75013 Paris, France.

Mary M Reilly (MM)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.

Henry Houlden (H)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.

Andrea Cortese (A)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.

Danielle Seilhean (D)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, Laboratoire Neuropathologie Raymond Escourolle, Pitié Salpêtrière University Hospital, Sorbonne Université, F-75013 Paris, France.

Alexis Brice (A)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, Genetics Department, Pitié Salpêtrière University Hospital, Sorbonne Université, Paris 75013, France.

Alexandra Durr (A)

Sorbonne Université, Paris Brain Institute, APHP, INSERM, CNRS, F-75013 Paris, France.
APHP, Genetics Department, Pitié Salpêtrière University Hospital, Sorbonne Université, Paris 75013, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH